Banff Human Organ Transplant Transcripts Correlate with Renal Allograft Pathology and Outcome: Importance of Capillaritis and Subpathologic Rejection

• Published in: Journal of the American Society of Nephrology Vol. 33; no. 12; pp. 2306 - 2319
• Main Authors: Rosales, Ivy A, Mahowald, Grace K, Tomaszewski, Kristen, Hotta, Kiyohiko, Iwahara, Naoya, Otsuka, Takuya, Tsuji, Takahiro, Takada, Yusuke, Acheampong, Ellen, Araujo-Medina, Milagros, Bruce, Amy, Rios, Andrea, Cosimi, Anthony Benedict, Elias, Nahel, Kawai, Tatsuo, Gilligan, Hannah, Safa, Kassem, Riella, Leonardo V, Tolkoff-Rubin, Nina E, Williams, Jr, Winfred W, Smith, Rex Neal, Colvin, Robert B
• Format: Journal Article
• Language: English
• Published: United States American Society of Nephrology 01-12-2022
• Subjects: Allografts; Antibodies; Clinical Research; Humans; Kidney Transplantation - adverse effects; Organ Transplantation; Transplantation, Homologous; Vascular Diseases; molecular biology; pathology; transplant pathology; kidney transplantation; renal biopsy; transplantation; mRNA; rejection
• ISSN: 1046-6673; 1533-3450
• DOI: 10.1681/ASN.2022040444

To seek insights into the pathogenesis of chronic active antibody-mediated rejection (CAMR), we performed mRNA analysis and correlated transcripts with pathologic component scores and graft outcomes.
We utilized the NanoString nCounter platform and the Banff Human Organ Transplant gene panel to quantify transcripts on 326 archived renal allograft biopsy samples. This system allowed correlation of transcripts with Banff pathology scores from the same tissue block and correlation with long-term outcomes.
The only pathology score that correlated with AMR pathways in CAMR was peritubular capillaritis (ptc). C4d, cg, g, v, i, t, or ci scores did not correlate. DSA-negative CAMR had lower AMR pathway scores than DSA-positive CAMR. Transcript analysis in non-CAMR biopsies yielded evidence of increased risk of later CAMR. Among 108 patients without histologic CAMR, 23 developed overt biopsy-documented CAMR within 5 years and as a group had higher AMR pathway scores (
=3.4 × 10
). Random forest analysis correlated 3-year graft loss with elevated damage, innate immunity, and macrophage pathway scores in CAMR and TCMR. Graft failure in CAMR was associated with TCMR transcripts but not with AMR transcripts, and graft failure in TCMR was associated with AMR transcripts but not with TCMR transcripts.
Peritubular capillary inflammation and DSA are the primary drivers of AMR transcript elevation. Transcripts revealed subpathological evidence of AMR, which often preceded histologic CAMR and subpathological evidence of TCMR that predicted graft loss in CAMR.